This brand name is authorized in Australia, Nigeria
The drug TELTARTAN contains one active pharmaceutical ingredient (API):
1
Telmisartan
UNII U5SYW473RQ - TELMISARTAN
|
Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
TELTARTAN Tablet | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C09CA07 | Telmisartan | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8355R, 8356T |
Country: NG | Registered Drug Product Database | Identifier(s): B4-8378, B4-8641 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.